Best Life Sciences Companies in Italy
The 499 best Life Sciences companies in Italy in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Medical Microinstruments.
Italy's Life Sciences sector doesn't have a unicorn yet, but $1.7B in disclosed funding across 499 tracked companies says the capital is moving. This directory ranks the best Life Sciences companies in Italy by disclosed equity funding and recent momentum, and the numbers tell a cleaner story than any pitch deck. AAVantgarde Bio leads the field at $206M raised, a figure that dwarfs the rest of the pack by a wide margin. Genenta Science sits at $34M. After that, you're looking at single-digit rounds from names like Cellply, Ulisse BioMed, and Haptena. The concentration is striking. One company holds roughly 12% of the sector's entire disclosed pool.
The broader market context matters here. Global life sciences tools are drawing serious analyst attention, with the sector tracking toward a market valued near $167.8B and a CAGR of around 10.2%, driven by an aging population and accelerating institutional funding. I'd note that Italy's investor mix reflects exactly that institutional tilt: Europa, EIC Fund, and CDP Venture Capital are the most active backers here, alongside UniCredit Start Lab and EIT Health. So the money isn't purely speculative. It's patient, structured, and increasingly policy-adjacent. Regulatory alignment with EU frameworks adds another layer of durability to the deals getting done.
- What Drives San Diego's Life Sciences Industry
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Italy
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Medical Microinstruments Provider of robotic platform using micro instruments for surgery 69Growth top 19%Moat top 26%Patents top 28%Innovation top 30% All 11 signals ▾Growthtop 19% Moattop 26% Patentstop 28% Innovationtop 30% Fundingtop 32% Techtop 42% Markettop 50% Fin. healthtop 50% Talentbottom 49% Globalbottom 44% Newsbottom 22% Growth: Revenue +444% YoY Moat: Editorial + unicorn rating 8/10 · IP moat: 168 patents rank vs industry peers · Fliar Intelligence Index 69/100 | $210M | 28 mo ago | 160 | Mark Toland Chief Executive Officer | WordPress Block EditorwpBakeryWordPress+31 | Top 5M | 168 patents Robotic microsurgical instruments and sterile teleoperation control interfaces for precision surgery | 1 award |
| 2 | AAVantgarde Bio Developer of gene therapies using Adeno-Associated Viral vectors | $206M | 7 mo ago | — | Alberto Auricchio Founder | GSAPMicrosoft ClarityGoogle Analytics+15 | Top 10M | — | — |
| 3 | Kedrion Developer of plasma-derived products for hemophilia and immune system deficiencies | $189M | 80 mo ago | 5,000 | Federico Latini Global Plasma CEO | WordPressApple iCloud MailMySQL+24 | Top 5M | — | — |
| 4 | NMS Group Developer of therapeutics for the treatment of cancer | $158M | 52 mo ago | 1 | Nancy Selling Founder | WordPressMySQLPHP+21 | Top 50M | — | — |
| 5 | Innovheart Provider of aesthetic devices for the treatment of atrioventricular valve diseases | $79M | 52 mo ago | 32 | Giovanni Righini Founder & CTO | WordPressMySQLPHP+16 | Top 50M | 144 patents Heart valve prostheses and associated implantation and crimping devices | — |
| 6 | Philogen Developer of antibody based drugs for angiogenesis-related cancer and inflammatory disorders | $70M | 85 mo ago | 157 | Dario Neri Co-Founder | WordPressMySQLPHP+16 | Top 5M | — | — |
| 7 | Genespire Developer of transformative gene therapies for people affected by genetic diseases | $69M | 20 mo ago | 10 | — | WordPressPleskMySQL+11 | Top 50M | 13 patents Design and production of lentiviral vectors for gene therapy applications | 1 award |
| 8 | AAVantgarde Bio Developer of gene therapies for inherited retinal disorders | $65M | 36 mo ago | 4 | Alberto Auricchio Co-Founder | — | — | — | — |
| 9 | Newron Pharmaceuticals Therapies for patients with diseases of the central nervous system and pain | $55M | 83 mo ago | 23 | — | DrupalPHPBootstrap+19 | Top 5M | 2 patents Synthesis of substituted phenethylamine alkaneamide pharmaceutical intermediates | 1 award |
| 10 | Enthera Developer of biotherapeutics for treating auto-immune disorders and type-1 diabetes | $46M | 64 mo ago | 15 | Gabriella Camboni Co-Founder | WordPressPleskMySQL+8 | Top 50M | 39 patents Therapeutic antibodies targeting TMEM219 and CD248 for disease treatment | — |
| 11 | Genenta Science Developer of lentivirus-based gene and cell therapies for cancer | $34M | 14 mo ago | 9 | Pierluigi Paracchi Co-Founder Chairman And Chief Executive Officer | DrupalPHPAmazon Web Services+29 | Top 10M | — | — |
| 12 | EryDel Developer of an erythrocyte encapsulation drug delivery system 19Funding top 44%Market bottom 36%Global bottom 36%News bottom 18% All 4 signals ▾Fundingtop 44% Marketbottom 36% Globalbottom 36% Newsbottom 18% Funding: Raised $31.7M across 2 rounds · 2 rounds over 13 yrs (0.2/yr) Market: 25 employees rank vs industry peers · Fliar Intelligence Index 19/100 | $32M | 97 mo ago | 25 | — | — | — | — | — |
| 13 | Empatica Developer of a wrist band to monitor physiological signals 64Tech top 23%Product top 34%Funding top 35%Growth top 35% All 11 signals ▾Techtop 23% Producttop 34% Fundingtop 35% Growthtop 35% Talenttop 38% Markettop 42% Moatbottom 44% Innovationbottom 43% Globalbottom 43% Customersbottom 41% Patentsbottom 38% Tech: 49 technologies across 6/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 Product: 5 published apps (41.5k installs) · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 64/100 | $31M | 42 mo ago | 133 | Melih Sadi Founder & Owner | SanityApple iCloud MailGoogle Workspace+23 | Top 1M | 2 patents Wearable electrodermal activity sensors with current‑compensation circuitry for accurate skin conductance monitoring | 1 job opening |
| 14 | WISE Provider of solutions for neuromodulation and neuromonitoring | $30M | 45 mo ago | 40 | — | — | — | 61 patents Patents concentrated in health & consumer products | — |
| 15 | Kither biotech Developer of treatments for rare pulmonary diseases | $27M | 51 mo ago | 8 | Emilio Hirsch Founder | WordPressMySQLPHP+31 | Top 50M | 38 patents Peptide therapeutics targeting PI3Kγ for fibroproliferative vascular disease treatment | — |
| 16 | GreenBone Provider of ortho implants to treat severe fractures and trauma conditions | $26M | 56 mo ago | 27 | Lorenzo Pradella Co-Founder & CEO | WordPressMySQLPHP+13 | Top 50M | — | 1 launch |
| 17 | Silicon Biosystems Developer of lab on a chip technologies for miniaturized cell-biology testing | $26M | 196 mo ago | 17,000 | — | DNNMicrosoft ASP.NETBootstrap+15 | Top 10M | 566 patents Advanced genomic amplification and single‑cell diagnostics for disease monitoring and prenatal testing | — |
| 18 | Sibylla Biotech AI-powered platform for drug discovery | $25M | 44 mo ago | 14 | Lidia Pieri Co-Founder & CEO | WordPressApple iCloud MailGoogle Workspace+16 | Top 50M | 3 patents Patents concentrated in computing, sensing & instrumentation | — |
| 19 | Resalis Therapeutics Developer of therapeutics for metabolic, oncology, and liver disease | $22M | 19 mo ago | 6 | — | WordPressMySQLPHP+8 | Top 50M | — | — |
| 20 | Altheia Science Developer of stem cell-based therapeutics for cancer and autoimmune diseases | $19M | 92 mo ago | 5 | — | WordPressMySQLPHP+29 | Top 50M | 15 patents Targeted immunotherapy and diagnostics for myeloid cancers using novel tumor-specific antigens | — |
| 21 | Endostart Developer of a guiding system for colonoscopy procedures | $19M | 45 mo ago | 13 | Alessandro Tozzi Founder & MD | — | — | 30 patents Magnetic navigation and guide systems for colonoscopic endoscopes | 1 award |
| 22 | BetaGlue Technologies Provider of a radiotherapy platform for the treatment of solid tumors | $19M | 24 mo ago | 14 | — | WordPressMySQLPHP+18 | Top 50M | — | 1 partnership · 1 award |
| 23 | General Medical Merate Manufacture X-ray diagnostics equipments | $16M | 167 mo ago | 300 | — | WordPressMySQLPHP+24 | Top 5M | 41 patents Advanced radiology imaging hardware: collimators and predictive control systems for X‑ray devices. | — |
| 24 | Tethis Provider of automated solutions for in liquid biopsy 53Patents top 26%Growth top 28%Innovation top 29%Funding top 40% All 8 signals ▾Patentstop 26% Growthtop 28% Innovationtop 29% Fundingtop 40% Moattop 45% Globalbottom 42% Techbottom 38% Marketbottom 35% Patents: 57 patents matched (strict assignee match) · 16 filings since 2022 vs 11 in 2017-21 Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $16M | 17 mo ago | 32 | — | WordPressMySQLPHP+18 | Top 10M | 57 patents Sample preparation and immobilization technologies for analytical and diagnostic bioassays | — |
| 25 | ViroStatics Early stage biotech developing antivirals (HIV and HPV) and onco drugs based on CDK Inhibitors | $13M | 106 mo ago | — | Franco Lori CEO | — | — | 3 patents Small‑molecule pyrimidine kinase inhibitors for therapeutic drug development | — |
| 26 | Newronika Developer of devices for neurodegenerative diseases | $11M | 16 mo ago | 16 | Alberto Priori Founder & President | WebflowCloudflare TurnstileHSTS+10 | Top 50M | 58 patents Adaptive deep brain stimulation devices for personalized neurological disease therapy | 2 job openings · 1 award |
| 27 | Angiodroid Provider of CO2 injector for diagnostic and interventional peripheral angiography 40AI top 15%Patents top 43%Moat top 45%Product top 46% All 10 signals ▾AItop 15% Patentstop 43% Moattop 45% Producttop 46% Fundingtop 50% Techtop 50% Innovationbottom 49% Marketbottom 40% Globalbottom 40% Growthbottom 35% AI: Holds AI/ML patents (G06N-family CPC) Patents: 27 patents matched (strict assignee match) · 11 filings since 2022 vs 16 in 2017-21 rank vs industry peers · Fliar Intelligence Index 40/100 | $10M | 39 mo ago | 36 | — | HubSpot CMS HubEnvoyBootstrap+19 | Top 5M | 27 patents Enhanced angiography imaging and gaseous contrast agent delivery systems | — |
| 28 | Arsenale BioYards Provider of platform for bio manufacturing with integrated hardware and software from lab to manufacturing | $10M | 15 mo ago | — | Niels Agerbaek Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+18 | Top 10M | — | 1 award |
| 29 | IAMA Therapeutics Developer of therapeutics for the treatment of neurological diseases | $9M | 14 mo ago | 4 | Marco Vivo Co-Founder | WordPressMySQLPHP+19 | Top 10M | 9 patents Synthesis of sulfamoylbenzoic acid derivatives and NKCC1‑targeting benzoimidazoles for chloride regulation | — |
| 30 | KLISBio Developer of regenerative implantable products by using silk fibroins | $9M | 121 mo ago | — | Antonio Alessandrino Co-Founder | RubyErlangTailwind CSS+12 | Top 50M | 3 patents Biomimetic peptide therapeutics for bone regeneration and tissue engineering | 1 award |
| 31 | Cellply Developer of in-vitro diagnostic products for the detection of cancer | $8M | 1 mo ago | 28 | Roberto Guerrieri Co-Founder | Node.jsVimeoTailwind CSS+15 | Top 50M | 43 patents Cell therapy product characterization and in‑vitro solid‑tumor activity screening | 1 launch · 1 partnership |
| 32 | ALKemist Bio Developer of cellular immunotherapies for ALK-positive cancers | $8M | 29 mo ago | — | Roberto Chiarle Founder | — | — | — | — |
| 33 | BionIT Labs Developer of myoelectric prosthesis limbs | $6M | 23 mo ago | 34 | Giovanni Zappatore Co-Founder & CEO | WordPressApple iCloud MailGoogle Workspace+21 | Top 10M | 16 patents Patents concentrated in transport & manufacturing processes | 1 launch · 1 partnership |
| 34 | Ulisse BioMed Manufacturer of biological drug monitoring and molecular diagnostics | $6M | 9 mo ago | 9 | Bruna Marini Co-Founder | PHPUbuntuBootstrap+11 | Top 50M | 32 patents Sensitive nucleic acid detection and analysis directly in crude biological samples | 1 launch · 1 partnership · 1 award |
| 35 | Alia Therapeutics Developer of gene therapies to cure rare genetic disorders | $5M | 38 mo ago | 10 | Gianluca Petris Co-Founder | WordPressPleskMySQL+10 | Top 50M | 24 patents CRISPR Cas protein engineering for genome editing and therapeutic applications | — |
| 36 | I-VASC Provider of a minimally invasive device for the treatment of varicose veins | $4M | 48 mo ago | 5 | Mario Salerno Founder & Chairman | — | — | 28 patents Patents concentrated in health & consumer products | — |
| 37 | Haptena Developer of immunotherapies targeting genetically defined cancers for durable patient options | $4M | 6 mo ago | — | Chiara Ambrogio Co-Founder | — | — | — | — |
| 38 | Ador Diagnostics Point of care IVD systems | $4M | 31 mo ago | — | Ari Tadmor CEO | — | — | 22 patents Microfluidic cartridge-based electrophoretic platforms for rapid point‑of‑care nucleic‑acid diagnostics | — |
| 39 | Diatech Pharmacogenetics Provider of diagnostic kits for pharmacogenetic tests | $3M | 37 mo ago | 60 | — | Cart FunctionalityWordPressMySQL+35 | Top 5M | — | 1 job opening · 2 partnerships |
| 40 | Prebiomics Provider of metagenomics technologies for developing kits for oral microbiome analysis | $3M | 37 mo ago | 9 | Paolo Ghensi CEO | WordPressMySQLPHP+19 | Top 50M | — | — |
| 41 | Wearable Robotics Exoskeletons and robotic rehabilitation devices 35Growth top 28%Moat top 38%Innovation top 44%Funding top 47% All 9 signals ▾Growthtop 28% Moattop 38% Innovationtop 44% Fundingtop 47% Patentstop 47% Talentbottom 49% Globalbottom 36% Techbottom 31% Marketbottom 23% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Moat: Editorial + unicorn rating 4/10 · IP moat: 6 patents rank vs industry peers · Fliar Intelligence Index 35/100 | $3M | 2 mo ago | 11 | Lucia Lencioni CEO & Managing Director | WordPressMySQLPHP+16 | Top 10M | 6 patents Mechanical transmission and actuation systems for wearable robotic devices | — |
| 42 | Valuebiotech Provider of a surgical robotic platform scar-free surgery | $3M | 44 mo ago | — | Antonello Forgione Co-Founder & CEO | — | — | 20 patents Robotic surgical systems: articulated arms, vision, and minimally invasive guidance devices. | — |
| 43 | Tensive Prostheses for a natural breast reconstruction | $2M | 16 mo ago | 18 | Valentina Morigi Co-founder and CFO | — | — | 23 patents Biodegradable 3D implantable scaffolds for tissue regeneration and breast reconstruction | 2 job openings · 1 internship |
| 44 | CaSRevolution Developer of therapeutics for neurological disorders | $2M | 36 mo ago | 3 | Gabriele Grecchi Co-Founder | — | — | 2 patents Aerobic in‑vitro cell culture platforms for physiological, pathological, pharmacological and toxicological research | — |
| 45 | approximamedical.com Developer of a minimally invasive device for the treatment of tricuspid valve | $2M | 15 mo ago | 6 | Edoardo Maroncelli Co-Founder | — | — | — | — |
| 46 | SENSE4MED Developer of smart sensors for various biomedical and environmental applications | $549K | 27 mo ago | — | Fabiana Arduini CEO | — | — | 5 patents Miniaturized electrochemical sensors and gas‑flow monitoring for point‑of‑care medical diagnostics | — |
| 47 | MgShell Developer of an intraocular device for drug delivery | $536K | 13 mo ago | 4 | Matteo Cereda Co-Founder | — | — | — | — |
| 48 | Medicud Developer of a medical device to treat exuding wounds | $518K | 14 mo ago | 8 | Andrea Cazzulani Co-Founder | — | — | 23 patents Flexible medical connectors for negative‑pressure therapeutic and diagnostic devices | — |
| 49 | Sestre Provider of dietary supplements for women's health | $447K | 20 mo ago | 4 | — | WordPressPleskMySQL+42 | Top 5M | 3 patents Oral nutraceutical formulations combining quercetin and bromelain for anti‑inflammatory effects | — |
| 50 | RECORNEA Provider of corneal implants devices for the treatment of eye diseases | $162K | 23 mo ago | 3 | Kakanga Moses Co-Founder | — | — | 11 patents Corneal implant devices for therapeutic ocular surgery and vision restoration. | — |
Top 12 Life Sciences companies in Italy
#1
Series B · Milano, Umbria · founded 2021$206.2Mraised▾
Developer of gene therapies using Adeno-Associated Viral vectors. It has two proprietary platforms leveraging DNA recombination and protein-intein fusion, to deliver large genes for various therapeutic applications. It offers two lead programs Usher syndrome type 1B associated with retinitis pigmentosa , using dual hybrid platform and for Stargardt disease, using AAV antgarde Intein-mediated platform.
- Nov 2025Series B$141M
- Jun 2023Series A$65.2M
- Jul 2021Seed—
#2
Series B · Bologna, Emilia Romagna · founded 2013 · 28 employees$8.1Mraised▾
Developer of in-vitro diagnostic products for the detection of cancer. The company has developed ONCOSMART is the first In-Vitro Diagnostic (IVD) system that determines the effectiveness of anticancer drugs for a specific patient, testing live cell response to one or multiple cancer drugs. Additionally, it offers prognostic tests based on the immune profile of hospitalized patients with Coronavirus Disease 19.
- May 2026Series B$8.4M
- Sep 2023Series A$3.8M
- Sep 2022Grant (prize money)$258K
- Dec 2021Seed$2.3M
#3
Series A · Pisa, Tuscany · founded 2014 · 11 employees$2.7Mraised▾
Exoskeletons and robotic rehabilitation devices. The major offerings from the firm are ALEx and Track-Hold. ALEx is a robotic exoskeleton and helps in movement and upper limb rehabilitation. Trackhold is a device for upper limb rehabilitation and passive training with support of gravity in special movements.
- Apr 2026Series A$5.8M
- Apr 2023Seed$2.7M
- Jan 2023Grant (prize money)$278.3K
#4
Public · Milan, Lombardy · founded 2014 · 9 employees$33.6Mraised▾
Developer of lentivirus-based gene and cell therapies for cancer. The lead candidateTemferon is a lentivirus-based hematopoietic stem progenitor cell immuno-gene therapy for Glioblastoma, solid tumor, and hematological malignancies. Also, has Tie2-Expressing Monocytes immunotherapies for multiple cancer treatment.
- Mar 2025Post IPO$21.9M
- Sep 2019Series C$14.6M
- Sep 2017Series B$8M
- Mar 2015Series A$11M
#5
Seed · Turin, Piedmont · founded 2025$3.5Mraised▾
Developer of immunotherapies targeting genetically defined cancers for durable patient options. The company integrates targeted therapies with immune-based approaches for challenging tumors. It focuses on enhancing precision oncology by targeting resistance mechanisms and tumor adaptation. The company is advancing its lead KRAS G12C program and building scalable paths for next-generation therapies.
- Dec 2025Seed$3.5M
#6
Series B · Udine, Friuli Venezia Giulia · founded 2015 · 9 employees$5.9Mraised▾
Manufacturer of biological drug monitoring and molecular diagnostics. Its sagitta platform offers molecular diagnostic test kits for the diagnosis and detection of respiratory infections, HPV, and also for Nucleic acid extraction. It also provides with drug monitoring platform with NanoHybrid technology to detect specific antibodies and protein analytes directly from serum or whole blood. The company is developing a full range of products to monitor patients prescribed with biologics or biosimilars, offering key information about drug availability and therapeutic efficacy.
- Sep 2025Series B$11.7M
- Sep 2022Grant (prize money)$258K
- 2017Series A$4.8M
- 2015Seed$1.1M
#7
Series B · Milano, Umbria · founded 2019 · 10 employees$69.3Mraised▾
Developer of transformative gene therapies for people affected by genetic diseases. The company's lead product includes GENE 101 for X-linked HIGM syndrome. Other candidates include GENE 102, 201, and 202 for inherited metabolic diseases.
- Sep 2024Series B$52M
- Apr 2020Series A$17.3M
#8
Series A · Milan, Lombardy · founded 2004 · 32 employees$15.8Mraised▾
Provider of automated solutions for in liquid biopsy. It offer a pre‑analytical workstation for blood samples at the collection siteand separates plasma and stabilizes cellular fraction directly on nanocoated SmartBioSurface microscope slides ideal for detecting circulating tumor cells (CTCs) and preserving cell-free plasma.
- Jan 2025PE$15.3M
- Aug 2018Grant (prize money)$58.4K
- May 2018Grant (prize money)$60K
- Jun 2016Grant (prize money)$340.2K
#9
Series C · Calci, Tuscany · founded 2015 · 160 employees$209.5Mraised▾
Provider of robotic platform using micro instruments for surgery. It uses a robotic platform that enables the use of microsurgical instruments for reconstruction procedures after traumatic injuries and tumor removal. The surgeons use the robotic platform which scales down the hand movements to the movements of the instruments during surgery. It claims that the product is the smallest robotic wrist.
- Feb 2024Series C$110M
- Jul 2022Series B$75M
- Apr 2018Series A$24.5M
#10
Series B · Genoa, Liguria · founded 2021 · 4 employees$8.9Mraised▾
Developer of therapeutics for the treatment of neurological diseases. The company's platform is to identify and advance diverse classes of small molecules to selectively inhibit the sodium-potassium chloride cotransporter (NKCC1) and other therapeutic targets relevant to treating central nervous system disorders including primary and secondary autism, epilepsy, and movement disorders.
- Apr 2025Series B$17.1M
- Apr 2022Series A$8.9M
#11
Series A · Turin, Piedmont · founded 2021 · 6 employees$21.6Mraised▾
Developer of therapeutics for metabolic, oncology, and liver disease. The company is developing anti-miRNA compounds based on locked nucleic acid technology to restore a healthy homeostat and regulate lipid metabolism to treat metabolic disorders, including NASH, obesity, and cancer.
- Oct 2024Series A—
- Jan 2024Series A$10.9M
- Feb 2023Seed$10.7M
- May 2022Seed—
#12
Series B · Cologno Monzese, Lombardy · founded 2016 · 16 employees$11.1Mraised▾
Newronika has developed a medical device for neurodegenerative diseases. The company has developed a product called AlphaDBS which is a closed-loop deep brain neuromodulation system used to interpret the bioelectrical neuronal activity. The company has also developed another product known as WebBioBank which is a web-based platform used by the researchers to collect, analyze, and interpret biosignals including also electronic health records data for patients going through neuromodulation treatment.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Italy
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,095 Italy-affiliated papers.
- University of Milan77
- University of Naples Federico II54
- University of Padua51
- University of Bologna49
- University of Bari Aldo Moro48
- Gene3→16
- Transcription (linguistics)1→7
- DNA damage3→8
- Mitochondrion1→5
- Phosphorylation1→4
- Antimicrobial1→15
- Quality (philosophy)1→15
- Antioxidant1→13
- Crop2→14
- Fermentation1→13
- Agriculture2→15
- Antibiotic resistance1→14
- Food safety2→12
- Sustainability1→8
- Livestock1→6
Where biotechnology is researched across Italy
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.